期刊文献+

慢性肝病网织血小板和血小板生成素的检测及临床意义 被引量:2

Clinical significance of measuring reticulate platelets and thrombopoietin in patients with chronic liver diseases
下载PDF
导出
摘要 目的:探讨网织血小板(RP)、血小板生成素(Tpo)与慢性肝病血小板减少的关系。方法:分别用流式细胞仪和ELISA方法测定正常人群及慢性肝病患者RP和Tpo水平。结果:①与正常人群比较,慢性肝炎、肝硬化患者RP绝对计数均显著降低;肝病患者血小板正常组与减少组比较RP和RP%均有显著性差异。②与正常人群比较,慢性肝炎、肝硬化患者Tpo水平均无显著性差异;而肝病患者血小板正常组与减少组比较Tpo水平有显著性差异。结论:血小板减少的慢性肝病患者存在血小板的生成减少,而Tpo水平下降可能是血小板生成减少的一个重要原因。 Objective: To measure the percentage and absolute counts of reticulated platelet(RP) and thrombopoietin(Tpo) levels in patients with chronic liver diseases. Methods: RP and Tpo were detected with ELISA and FCM method in patients with liver diseases and healthy controls. Results: ①The RP count of patients with chronic hepatitis and liver cirrhosis(LC ) was significantly low- er than that of normal people;The RP count and RP% were significanly different in chronic liver diseases patients with normal or abnormal platelet. ②Tpo level was not significantly different among patients with chronic hepatitis, liver cirrhosis and healthy controls; Patients with normal platelet counts showed higher thrombopoietin level than those with low platelet counts. Conclusion: These findings suggest that patients with chronic liver diseases patients with thrombocytopenia present decreased platelet,and decreased Tpo level may be one important reason for decreased platelet level.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第8期680-682,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 慢性肝炎 肝硬化 网织血小板 血小板生成素 血小板 chronic hepatitis liver cirrhosis reticulate platelets thrombopoietin platelet
  • 相关文献

参考文献12

  • 1Briggs C,Kunka S,Hart D,et al.Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia[J].Br J Haematol,2004,126(1):93-99
  • 2Kuwana M,Okazaki Y,Satoh T,et al.Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura[J].Am J Med,2005,118(9):1026-1033
  • 3Rajantie J,Javela K,Joutsi Korhonen L,et al.Chronic thrombocytopenia of childhood:use of non-invasive methods in clinical evaluation[J].Eur J Haematol,2004,72(4):268-272
  • 4Qian S,Fu F,Li W,et al.Primary role of the lier in thrombopoietin production shown by tissue-specific knockout[J].Blood,1998,92:2189-2191
  • 5Rios R,Sangro B,Herrero I,et al.The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis[J].Am J Gastroenterol,2005,100(6):1311-1316
  • 6中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 7Sanjo A,Satoi J,Ohnishi A,et al.Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases[J].J Gastroenterol Hepatol,2003,18:638-644
  • 8Leitner GC,Stiegler G,Horvath M,et al.Idiopathic autoimmune thrombocytopenia:evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment[J].Am J Hematol,2003,73 (1):44-47
  • 9Kurata Y,Hayashi S,Kiyoi T,et al.Diagnostic value of tests for reticulated platelets,plasma glycocalicin,and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia[J].Am J Clin Pathol,2001,115(5):656-664
  • 10叶军,张立新,李加新,陈亚宝.肝病患者血清血小板生成素水平的观察[J].临床检验杂志,2005,23(6):459-459. 被引量:4

二级参考文献17

  • 1谌建军,王彦君,刘明刚.病毒性肝炎患者血清γ-谷氨酰转肽酶水平与预后的关系[J].黑龙江医学,2004,28(8):621-622. 被引量:5
  • 2De Sauvage FJ, Luoh SM, Carver-Moore K, et al. Deficiencies in early and late stages megakaryocytopoiesis in TPO-KO mice. J Exp Med, 1996, 183: 651-656.
  • 3De Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.Nature, 1994, 369: 533-538.
  • 4Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost, 1998, 79:1106-1110.
  • 5Sanjo A, Satoi J, Ohnishi A, et al. Role of elevated platelet-associated immunoglobnlin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol, 2003, 18: 638-644.
  • 6Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood, 2002, 100: 3457-3469.
  • 7Goulis J, Chau TN, Jordan S, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia are restored after orthotopic liver transplantation. Gut, 1999, 44: 754-758.
  • 8Stockelberg D, Andersson P, Bjornsson E, et al. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J Intern Med,1999, 246: 471-475.
  • 9Shimodaira S, Ishida F, Ichikawa N, et al. Serum thrombopoietin (cMpl ligand) levels in patients with liver cirrhosis. Thromb Haemost,1996, 76: 545-548.
  • 10Peck-Radosavljevic M, Wichlas M, Zadel J, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood, 2000,95: 795-801.

共引文献14048

同被引文献23

引证文献2

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部